International Searching and Preliminary Examining Authorities

Life Spine Announces Issuance of 200th Patent

Retrieved on: 
Wednesday, March 31, 2021
Biotechnology, Surgery, Medical devices, Hospitals, Health, Intellectual property law, International Searching and Preliminary Examining Authorities, Patent offices, Monopoly, Patent, United States Patent and Trademark Office, Spine, United States patent law

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received notice of issuance from the U.S. Patent and Trademark Office (USPTO) regarding U.S. Patent No.

Key Points: 
  • Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received notice of issuance from the U.S. Patent and Trademark Office (USPTO) regarding U.S. Patent No.
  • 10,973,553, which signifies Life Spines 200th patent to date.
  • With our 200th patent granted, Life Spine has one of the highest patent outputs per employee in the industry and this rich IP portfolio is a key driver to our success, said Michael Butler, Life Spine President and CEO.
  • Life Spine is dedicated to improving the quality of life for spinal patients by increasing procedural efficiency and efficacy through innovative design, uncompromising quality standards, and the most technologically advanced manufacturing platforms.

Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel DNA-Damaging Agent with Anticancer Properties

Retrieved on: 
Wednesday, March 17, 2021
Countries, Foreign relations, Government, Monopoly, Patent, International Searching and Preliminary Examining Authorities, Patent offices

platform to transform oncology drug discovery and development today announced that it has filed seven patent applications globally on a novel DNA-damaging agent with anticancer properties.

Key Points: 
  • platform to transform oncology drug discovery and development today announced that it has filed seven patent applications globally on a novel DNA-damaging agent with anticancer properties.
  • Based on Lantern's previously filed PCT ("Patent Cooperation Treaty") patent application, Lantern has filed national stage patent applications to seek protection for LP-284 in major market countries throughout the world.
  • The national stage patent applications allow, if granted, for patent protection of LP-284.The filed, multi-national patent applications are directed to both the composition and manufacture of LP-284.
  • These seven patent applications are consistent with our focus on becoming a leader in the global development of precision oncology therapies," said Mr. Sharma of Lantern Pharma.

Annovis Bio Receives Japanese Patent for the Treatment of Acute Brain or Nerve Injury

Retrieved on: 
Wednesday, March 10, 2021
Intellectual property law, Patent offices, Patent law, International Searching and Preliminary Examining Authorities, European Patent Organisation, Intellectual property organizations, European Patent Office, United States Patent and Trademark Office, Patent office, Patent

"This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases," commented Maria Maccecchini, Ph.D., CEO of Annovis.

Key Points: 
  • "This new patent further strengthens our intellectual property focused on the treatment of neurodegenerative diseases," commented Maria Maccecchini, Ph.D., CEO of Annovis.
  • "We believe there are additional opportunities to expand our patent coverage both globally and in the US.
  • The Company received its first PD patent (US 10,383,851) from the USPTO in August 2019 and its first AD patent (EP 2683242) from the European Patent Office (EPO) in March 2020.
  • The EPO approved Annovis Bio's first acute patent (EP 3334425B1) in December 2020.

Clarification of Previously Announced Press Release: SoLVBL Solutions Inc. Announces Update on the Second Provisional Patent Application

Retrieved on: 
Tuesday, March 9, 2021
Intellectual property law, United States patent law, Intangible assets, International Searching and Preliminary Examining Authorities, Patent offices, Provisional application, Patent, United States Patent and Trademark Office, Trademark, Term of patent in the United States, Outline of patents

Provisional Patent Application" (the "Original Press Release").

Key Points: 
  • Provisional Patent Application" (the "Original Press Release").
  • Due to recent queries regarding the Original Press Release, the following press release provides additional information and clarification on certain statements regarding filing of the Second U.S.
  • Provisional Patent Application with the United States Patent and Trademark Office (the "Second U.S.
  • In the Original Press Release, the Company set out the parameters of the Second U.S.

Croatia grants Lleida.net a patent for its method of receiving certified emails

Retrieved on: 
Tuesday, February 23, 2021
Patent offices, Intangible assets, Intellectual property law, International Searching and Preliminary Examining Authorities, SIPO, Patent, China National Intellectual Property Administration, State Intellectual Property Office, Intellectual property, Trademark, Outline of patents

This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.

Key Points: 
  • This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.
  • The grant follows a patent granted for this method by the European Patent and Trademark Office in 2019.
  • It is also the method used by the Spanish FootballLeague for its audiovisual rights auction.
  • Lleida.net, which has more than 3,000 shareholders, is listed on BME Growth in Madrid, the OTCQX index in New York and Euronext Growth in Paris.

Croatia grants Lleida.net a patent for its method of receiving certified emails

Retrieved on: 
Tuesday, February 23, 2021
Patent offices, Intangible assets, Intellectual property law, International Searching and Preliminary Examining Authorities, SIPO, Patent, China National Intellectual Property Administration, State Intellectual Property Office, Intellectual property, Trademark, Outline of patents

This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.

Key Points: 
  • This patent, granted in Zagreb by theCroatianState Intellectual Property Office (SIPO), is valid for 20 years.
  • The grant follows a patent granted for this method by the European Patent and Trademark Office in 2019.
  • It is also the method used by the Spanish FootballLeague for its audiovisual rights auction.
  • Lleida.net, which has more than 3,000 shareholders, is listed on BME Growth in Madrid, the OTCQX index in New York and Euronext Growth in Paris.

Hapbee Announces Filing of Provisional Patent Application for Bed-Related Form Factor

Retrieved on: 
Friday, February 19, 2021
Intellectual property law, United States patent law, International Searching and Preliminary Examining Authorities, Patent offices, Provisional application, Patent application, Patent, United States Patent and Trademark Office, Wearable, Magnetic field

VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee"or the "Company"), a wellness technology company utilizing groundbreaking magnetic field technology in its Hapbee wearable, is pleased to announce it has filed a provisional patent application for its bed-related form factor with the United States Patent and Trademark Office ("USPTO").

Key Points: 
  • VANCOUVER, BC, Feb. 19, 2021 /PRNewswire/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee"or the "Company"), a wellness technology company utilizing groundbreaking magnetic field technology in its Hapbee wearable, is pleased to announce it has filed a provisional patent application for its bed-related form factor with the United States Patent and Trademark Office ("USPTO").
  • The provisional patent application covers a body support system that emits ultra-low radio frequency energy (ulRFE) expected to produce predefined sensations (e.g., calm, sleepy, relax, alert, focus).
  • Hapbee has completed the Industrial Design phase of prototype development for the aforementioned bed-related form factor and has entered the Engineering Design phase of the project.
  • Hapbee is a wearable magnetic field technology company that aims to help people choose how they feel.

SVI Begins Development of Multi-Modal Dual Chirp FMCW 4D LiDAR System for Remote ID and Threat Detection Using Heartbeat, Breathing Rate and Gait Following Issuance of Key Patent

Retrieved on: 
Wednesday, February 17, 2021
Intellectual property law, Intangible assets, Patent law, International Searching and Preliminary Examining Authorities, Patent offices, Patent, United States Patent and Trademark Office, Trademark

The initiation of this development process follows the United States Patent and Trademark Office granting SVI patent no.

Key Points: 
  • The initiation of this development process follows the United States Patent and Trademark Office granting SVI patent no.
  • The patent is one of more than 100 worldwide patents and patents pending issued to SVI covering its field-proven and uniquely capable technology.
  • Its further detection of heart and breathing rate, eye movement and speech can provide indications of alertness, psychological condition or intent.
  • The technology can measure velocity down to millimeters per second, allowing the remote detection of heart and breathing rate and speech (U.S. patent no.

Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds

Retrieved on: 
Friday, February 5, 2021
Intellectual property law, United States patent law, International Searching and Preliminary Examining Authorities, Patent offices, Entheogens, Intellectual property organizations, Provisional application, Patent application, United States Patent and Trademark Office, Psilocybin, Psychedelic drug, Patent

The applications include both novel prodrug and deuterated derivatives of psilocybin, which could be candidates for the expedited 505(b)2 approval pathway, as well as potential novel sidechain-restricted psilocybin-inspired psychedelics.

Key Points: 
  • The applications include both novel prodrug and deuterated derivatives of psilocybin, which could be candidates for the expedited 505(b)2 approval pathway, as well as potential novel sidechain-restricted psilocybin-inspired psychedelics.
  • The elegant design of these compounds has drawn on multiple decades of drug design, medicinal chemistry and drug development by the Mindset scientific team.
  • Both the USPTO and PCT patent applications claim priority dates of the Company's previously filed USPTO provisional applications, which were filed on February 4, 2020.
  • The compounds covered under these 2 patent applications are currently undergoing in vivo screening.

Intellectual Property / Tech Law Firm Reaches #13 on Top Patent Firms List in Biotechnology & Organics Field

Retrieved on: 
Friday, January 29, 2021
Intellectual property law, Intellectual property organizations, International Searching and Preliminary Examining Authorities, Patent offices, United States Patent and Trademark Office, United States trademark law, Patent application, United States patent law, Patent

Technology center 1600 at the US Patent Office (USPTO) specializes in the examination of U.S. patent applications in the areas of biotechnology and organic chemistry.

Key Points: 
  • Technology center 1600 at the US Patent Office (USPTO) specializes in the examination of U.S. patent applications in the areas of biotechnology and organic chemistry.
  • "Our continued success reflects the hard work and dedication of our attorneys and staff.
  • It is an honor to once again top Harrity's Top Patent Firms List," said Susan McBee, Managing Partner.
  • MMV was founded in 2016 and is a boutique patent law firm that strives to provide more efficient and streamlined services to clients at a reasonable cost.